JANNA OSTWALT: Open Payments
NPI 1275199341 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 39 payments from 19 companies in 2025. Trend: 2023 $455 · 2024 $724 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Lilly USA, LLC | 4 | $63 |
| Grifols USA, LLC | 2 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Corcept Therapeutics | 2 | $47 |
| Esperion Therapeutics, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $42 |
| Abbott Laboratories | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
Products named: REXULTI, MOUNJARO, Prolastin-C Liquid, JARDIANCE, Korlym, NEXLETOL, Wegovy, FREESTYLE LIBRE 3.
Industry payments across NC — which companies pay providers there.
